Bayer Austria GmbH You have been with Bayer for almost 15 years. What would you say defines your loyalty to the company, and has the time so far met your original expectations? Bayer is a great company today; it was also a great company when I joined in 1998. The fascination with innovation…
Meda Pharma Austria What have been the most significant developments as a result of the acquisition of Viatris by Meda Pharma in 2005? At that time Viatris was a small company, and there was a distinct lack of enthusiasm and forward thinking strategy. Because the financial investors running Viatris wanted to sell the…
Biotest Austria What initially attracted you to Biotest back in 2001 and what do you think attracts industry professionals to Biotest today? I started my pharmaceutical career at Behring in Austria, doing basic jobs such as visiting doctors as a representative, and I also worked as a product manager. During this time…
Dr Reddy's Laboratories Australia Dr. Reddy’s entered Australia under your leadership. Would you outline the key milestones & achievements? Our first product was available to us for commercialization in Jan 2010 and since then we have grown rapidly on several parameters , about 1000 community pharmacies buy Dr.Reddy’s products directly , we also work…
Celgene Australia In our interviews we have been hearing two opinions on the success of PBS reforms: that it works as it should in providing space for innovative medicine listings, and that the number of listings has decreased to a point where Australia is in danger of losing its attractiveness as an…
Celgene Australia “Australia is not just a postbox for selling drugs; Celgene is committed to establishing a major presence in the region,” you said when Focus Reports met you first in 2008. Since then, what have been the highlights in the Celgene development in this part of the world? When Celgene decided…
Array After just six months in the country, Novartis Australia’s new Managing Director offers his perspectives on the Australian pharmaceutical market and healthcare system, his company’s commitment to R&D, and Australia’s competitiveness for clinical trials in the Asian context. You arrived in July 2012 after working in different positions for…
Leo Pharma Austria You have been managing LEO Pharma’s Austrian operations since March 2012. How do you look back at these first few months? And what have been your first initiatives at the head of the affiliate? 2012 has overall been an interesting year, as LEO Pharma stepped into new fields of indication…
Novo Nordisk - Australia Can you start by commenting on the state of diabetes in Australia at present? According to 2011 statistics nearly one million Australians have diabetes and about half of those are not aware that they have the condition. Australia is ranked 7th in the world in terms of prevalence of type…
Merck Sharp & Dohme Austria You have been the head of MSD’s Austrian operations since April 2009. Can you start by telling our readers about the evolution of the affiliate since the merger with Schering Plough? I have been with MSD Austria since before the merger, I started in early 2009 when the merger had…
Ausbiotech What have been the focus areas for the association in improving the wellbeing of the life science biotech industry and what have been the key milestones/achievements since 2008 in providing representation and services to promote the global growth of Australian biotechnology? In addition to the financial crisis the government decided…
See our Cookie Privacy Policy Here
